CARMONA JOSE (Chief Financial Officer) received a stock award from ADC THERAPEUTICS SA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2026ACC: 0001628280-26-009278
Officer· Chief Financial Officer
Since Feb 2026
+245.72K
Net shares
Net buyer
$103.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
271.60K acquired · 25.88K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+271.60K
Price / share
$3.99
Trade value
$1.08M
% of position
55.6%
2/13/2026
488.66K→760.26K
Common Shares
Direct
Shares
−25.88K
Price / share
$3.99
Trade value
$103.26K
% of position
3.4%
2/13/2026
760.26K→734.38K
Total
Net shares
+245.72K
Net value
$980.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/13/2026 | A · Award | +271.60K | $3.99 | $1.08M | 55.6% | 488.66K | 760.26K |
| Common Shares Direct | 2/13/2026 | F · Tax Withholding | −25.88K | $3.99 | $103.26K | 3.4% | 760.26K | 734.38K |
| Total | +245.72K | $980.42K | ||||||
Derivative Transactions0
No derivative transactions reported